safe
effect
deliveri
rna
interfer
rnai
therapeut
remain
import
challeng
clinic
develop
divers
current
deliveri
materi
remain
limit
part
slow
multistep
synthes
describ
new
class
lipidlik
deliveri
molecul
term
lipidoid
deliveri
agent
rnai
therapeut
chemic
method
develop
allow
rapid
synthesi
larg
librari
structur
divers
lipidoid
librari
identifi
lipidoid
facilit
high
level
specif
silenc
endogen
gene
transcript
formul
either
doublestrand
small
interf
rna
sirna
singlestrand
antisens
oligoribonucleotid
target
microrna
mirna
safeti
efficaci
lipidoid
evalu
three
anim
model
mice
rat
nonhuman
primat
studi
report
suggest
materi
may
broad
util
local
system
deliveri
rna
therapeut
specif
reduct
silenc
gene
express
rnai
consider
potenti
creat
new
class
therapeut
address
previous
untreat
diseas
high
dose
cholesterolmodifi
sirna
cholesterolmodifi
oligoribonucleotid
antagomir
demonstr
reduc
gene
express
specif
vivo
liver
tissu
certain
virus
respiratori
syncyti
viru
inhibit
local
administr
nake
sirna
recent
system
deliveri
sirna
liver
mice
nonhuman
primat
demonstr
use
lipid
formul
despit
advanc
publish
report
demonstr
efficaci
system
deliv
sirna
primat
although
signific
effort
dedic
cation
lipid
deliveri
system
develop
safe
effect
method
vitro
vivo
proven
challeng
date
deliveri
sirna
mediat
direct
conjug
deliveri
agent
rna
moieti
formul
use
lipid
peptidebas
deliveri
system
recent
complex
antibodi
fusion
protein
key
barrier
explor
deliveri
materi
space
new
materi
synthesi
convent
lipid
synthesi
typic
requir
individu
optim
multiplestep
synthesi
includ
timeintens
procedur
chemic
protect
deprotect
use
remov
catalyst
solvent
exchang
purif
custom
synthet
reaction
multipl
step
requir
limit
throughput
correspondingli
limit
abil
gener
substanti
librari
size
divers
address
problem
develop
chemic
method
capabl
rapid
parallel
gener
lipidlik
molecul
fig
supplementari
method
onlin
synthesi
scheme
base
upon
conjug
addit
alkylacryl
alkylacrylamid
primari
secondari
amin
fig
particular
chemistri
unlik
mani
tradit
lipid
synthesi
chemistri
allow
reaction
absenc
solvent
catalyst
result
lipidoid
product
therebi
elimin
need
protect
deprotect
step
purif
concentr
step
supplementari
method
supplementari
tabl
onlin
detail
synthesi
character
use
method
first
synthes
pilot
librari
nearli
lipidoid
member
number
paramet
systemat
vari
includ
alkyl
chain
length
ii
linkag
alkyl
chain
amin
degrad
ester
stabl
amid
iii
primari
r
group
amin
iv
postsynthet
introduct
constitut
posit
charg
certain
lipidoid
quatern
amin
alkyl
agent
methyl
iodid
character
repres
lipidoid
demonstr
nearli
complet
conjug
acrylatebas
lipidoid
condit
use
supplementari
method
acrylamid
conjug
slower
one
week
elev
temperatur
major
materi
conjug
supplementari
method
combinatori
approach
advantag
simpl
rapid
synthesi
well
potenti
gener
larg
divers
collect
materi
synthes
first
librari
screen
abil
deliv
sirna
hela
cell
line
stabli
express
firefli
photinu
pyrali
renilla
renilla
reniformi
luciferas
fig
efficaci
sirna
deliveri
lipidoid
determin
treat
cell
sirnalipidoid
complex
prepar
use
firefli
luciferasetarget
sirna
siluc
measur
ratio
firefli
renilla
luciferas
express
assay
toxic
nonspecif
effect
result
reduct
express
luciferas
protein
wherea
noncytotox
specif
silenc
result
reduct
firefli
luciferas
facilit
screen
throughput
form
sirnalipid
complex
simpl
mix
sirnalipidoid
solut
microtit
plate
analysi
result
reveal
sever
trend
lipidoid
capabl
deliv
sirna
hela
cell
overal
enhanc
deliveri
perform
achiev
use
lipidoid
contain
two
amin
per
head
unit
eg
monom
furthermor
effect
materi
often
either
two
long
amid
tail
eg
n
sever
smaller
amid
tail
eg
base
data
set
synthes
secondgener
librari
lipidoid
expand
structur
test
base
trend
particular
hypothes
number
design
featur
could
enrich
librari
effect
materi
specif
expand
librari
includ
lipidoid
even
shorter
amid
tail
eg
n
n
head
unit
eg
monom
mani
head
unit
potenti
form
two
tail
lipidoid
resynthes
vari
reaction
stoichiometri
gener
lipidoid
divers
number
tail
ratio
deliveri
materi
nucleic
acid
known
affect
deliveri
potenti
formul
therefor
second
gener
librari
lipidoid
screen
deliveri
hela
cell
four
differ
lipidoidsirna
ratio
quadrupl
use
screen
method
identifi
lipidoid
induc
gene
silenc
level
similar
commerci
avail
vitro
transfect
agent
lipofectamin
fig
notabl
top
perform
lipidoid
second
librari
contain
sever
structur
similar
amid
linkag
ii
two
alkyl
tail
iii
tail
length
rang
carbon
iv
one
tail
short
total
substitut
amin
reactant
therefor
contain
one
secondari
amin
rel
short
tail
surpris
comparison
typic
gene
deliveri
lipid
dotap
dotma
contain
aliphat
carbon
atom
notabl
mani
effect
lipidoid
structur
unlik
either
convent
lipid
cation
polym
eg
synthes
set
effect
sirna
deliveri
materi
substanti
expand
collect
chemic
divers
materi
known
facilit
sirna
deliveri
cell
close
examin
vitro
perform
test
collect
purifi
lipidoid
select
show
efficaci
hela
cell
differ
dose
three
cell
type
hela
human
hepatocellular
liver
carcinoma
cell
line
primari
bone
marrowderiv
murin
macrophag
fig
vitro
analysi
show
gener
lipidoid
commerci
lipid
rel
noncytotox
concentr
rang
efficaci
supplementari
fig
onlin
notabl
lipidoid
perform
differ
differ
cell
type
wherea
materi
abl
facilit
good
silenc
highest
sirna
level
commerci
reagent
lipofectamin
rnaimax
lipofectamin
abl
facilit
greater
silenc
lowest
sirna
level
hela
cell
contrast
primari
bone
marrowderiv
macrophag
lipidoid
effect
deliveri
vehicl
low
sirna
concentr
dosedepend
silenc
green
fluoresc
protein
gfp
express
observ
lipidoid
test
silenc
observ
even
sirna
concentr
fig
contrast
lipofectamin
lipofectamin
rnaimax
effect
silenc
gfp
express
even
higher
sirna
concentr
fig
wherea
overal
silenc
low
complex
concentr
hela
cell
line
less
commerci
reagent
lipidoid
provid
effect
silenc
primari
bone
marrowderiv
macrophag
librari
approach
provid
substanti
number
new
materi
may
use
transfect
cell
thu
far
proven
refractori
transfect
current
avail
reagent
examin
util
librari
first
test
lipidoid
vivo
system
deliveri
sirna
liver
liver
repres
attract
organ
therapeut
intervent
number
potenti
hepat
target
highli
perfus
natur
organ
may
render
amen
deliveri
exogen
sirna
use
liverdirect
vivo
screen
lipidoid
librari
identifi
seri
compound
facilit
high
level
sirnamedi
gene
silenc
hepatocyt
cell
compris
liver
parenchyma
factor
vii
blood
clot
factor
ideal
target
gene
assay
function
sirna
deliveri
liver
factor
produc
specif
hepatocyt
gene
silenc
indic
success
deliveri
parenchyma
oppos
deliveri
cell
reticuloendotheli
system
eg
kupffer
cell
furthermor
factor
vii
secret
protein
readili
measur
serum
obviat
need
euthan
anim
final
protein
short
halflif
h
silenc
mrna
level
manifest
silenc
protein
level
minim
lag
seventeen
topperform
lipidoid
identifi
vitro
screen
formul
vivo
use
complex
contain
lipidoid
cholesterol
peglipid
gener
simpl
ionic
complex
suitabl
vivo
system
administr
owe
poor
serum
stabil
tendenc
form
aggreg
poor
vivo
toler
least
seven
lipidoid
formul
identifi
mediat
signific
reduct
serum
factor
vii
protein
level
largest
reduct
observ
fig
five
variant
contain
differ
tail
number
purifi
test
individu
supplementari
fig
onlin
found
optim
vivo
deliveri
verifi
specif
gene
silenc
liver
mrna
level
measur
factor
vii
anoth
hepatocyteexpress
gene
apolipoprotein
b
apob
fig
anim
treat
formul
contain
sifvii
silenc
factor
vii
mrna
observ
convers
anim
treat
formul
contain
apobspecif
sirna
siapob
silenc
apob
mrna
observ
administr
lipidoidformul
wtwt
mixtur
two
sirna
result
silenc
factor
vii
apob
gene
detect
loss
potenc
competit
sirna
silenc
factor
vii
observ
mismatch
factor
vii
sirna
use
data
shown
data
indic
observ
gene
silenc
direct
result
specif
effect
lipidoidsirna
mrna
level
liver
effect
applic
multipl
hepatocyteexpress
gene
explor
vivo
activ
observ
mice
conduct
efficaci
toler
studi
rat
rat
given
singl
intraven
iv
inject
sifvii
formul
dose
mgkg
signific
dosedepend
reduct
liver
factor
vii
mrna
level
observ
silenc
mgkg
respect
fig
supplementari
tabl
onlin
silenc
observ
use
formul
control
sirna
sicont
demonstr
specif
silenc
reduct
liver
factor
vii
mrna
level
produc
concomit
dosedepend
reduct
serum
factor
vii
protein
level
nearli
complet
silenc
highest
dose
level
fig
would
expect
significantli
reduc
serum
factor
vii
level
produc
phenotyp
effect
treat
anim
factor
vii
part
extrins
coagul
pathway
treat
anim
impair
clot
pathway
measur
prolong
prothrombin
time
fig
phenotyp
effect
found
specif
attribut
deliveri
vehicl
formul
control
group
demonstr
perturb
prothrombin
time
result
gene
silenc
highli
sustain
singl
inject
formul
factor
viitarget
sirna
sifvii
capabl
mediat
silenc
persist
nearli
week
fig
next
investig
toler
formul
rat
anim
receiv
four
onceperweek
iv
bolu
inject
formul
sirna
dose
high
mg
kgweek
nonphysiolog
sirna
sicont
use
elimin
potenti
target
silencingrel
toxic
formul
gener
welltoler
dose
level
test
determin
cagesid
observ
measur
clinic
chemistri
hematolog
paramet
tabl
howev
enlarg
spleena
major
clearanc
organ
nanoparticleswa
observ
highest
dose
appear
weight
organ
normal
examin
addit
diseas
model
explor
versatil
lipidoid
approach
local
sirna
deliveri
lung
intranas
administr
test
mous
model
respiratori
syncyti
viru
infect
fig
separ
experi
confirm
absenc
gene
silenc
liver
kidney
local
pulmonari
administr
formul
data
shown
wherea
nake
sirna
provid
roughli
one
log
reduct
viral
plaqu
sirna
dose
provid
greater
two
log
reduct
viral
plaqu
data
demonstr
lipidoid
use
nonsystem
applic
rnai
technolog
capabl
deliv
sirna
nonhepat
cell
type
macrophag
cell
type
frequent
implic
patholog
inflammatori
diseas
follow
success
transfect
sirna
primari
macrophag
vitro
cultur
fig
test
whether
lipidoidformul
sirna
mediat
silenc
macrophag
vivo
mice
inject
intraperiton
thioglycol
steril
inflamm
stimulu
follow
inject
reduct
protein
express
observ
periton
macrophag
popul
fig
although
intraperiton
administr
circumv
local
challeng
associ
system
deliveri
periton
macrophag
result
indic
lipidoid
formul
potenti
use
deliveri
sirna
macrophag
vivo
examin
util
lipidoid
materi
deliveri
nucleic
acid
therapeut
drug
test
potenti
facilit
deliveri
singlestrand
oligoribonucleotid
target
mirna
antimir
vivo
deliveri
antimir
result
silenc
specif
target
mirna
consequ
upregul
specif
gene
regul
target
mirna
dose
mgkg
consecut
day
mice
result
greater
repress
cholesterolconjug
version
oligoribonucleotid
dose
mgkg
consecut
day
fig
effect
shown
specif
mismatch
control
result
appreci
effect
consist
downregul
gene
target
shown
derepress
mice
rel
mismatch
control
fig
determin
effect
lipidoid
third
anim
speci
initi
studi
nonhuman
primat
cynomolgu
monkey
treat
singl
iv
inject
lipidoidformul
siapob
sirna
dose
mgkg
separ
control
anim
treat
either
salin
lipidoidformul
sicont
serum
sampl
taken
anim
administr
determin
extent
durat
serum
apob
protein
silenc
silenc
apob
observ
dosedepend
manner
maxim
serum
apob
reduct
rel
predos
level
fig
contrast
signific
silenc
observ
salin
formul
control
group
indic
specif
activ
formul
apob
sirna
silenc
remark
persist
anim
highdos
group
singl
iv
bolu
inject
lowest
level
apob
achiev
rapidli
day
silenc
still
maintain
week
full
recoveri
express
achiev
month
later
data
herein
regard
durabl
apob
silenc
extend
previou
report
system
rnai
nonhuman
primat
report
zimmermann
et
al
studi
termin
consist
apob
silenc
therapeut
efficaci
measur
specif
persist
reduct
lowdens
lipoprotein
cholesterol
ldlc
also
observ
supplementari
fig
onlin
subsequ
primat
studi
perform
nextgener
lipidoidbas
formul
cynomolgu
monkey
formul
optim
part
maxim
sirna
load
lipidoid
complex
notabl
total
mass
deliveri
materi
rel
sirna
formul
roughli
onethird
previous
publish
stabl
nucleic
acid
lipid
particl
snalp
deliveri
system
also
unlik
previous
publish
snalp
system
formul
contain
fewer
total
compon
three
differ
agent
plu
sirna
instead
four
anim
treat
formul
apob
sirna
sirna
dose
mgkg
formul
control
sirna
mgkg
administ
via
singl
iv
inject
tissu
harvest
h
administr
liver
mrna
determin
silenc
apob
liver
mrna
observ
fig
correspond
maxim
reduct
serum
apob
protein
fig
earli
administr
ldlc
reduc
fig
toxicolog
analysi
indic
formul
well
toler
dose
level
test
observ
treatmentrel
chang
appear
behavior
clinic
relev
chang
coagul
hematolog
paramet
observ
mild
reduct
platelet
highest
dose
signific
chang
clinic
chemistri
paramet
observ
except
slight
increas
alanin
aminotransferas
alt
aspart
aminotransferas
ast
elev
less
observ
previous
publish
snalp
formul
tabl
supplementari
tabl
onlin
rnai
technolog
pois
form
basi
next
major
class
pharmaceut
drug
howev
effect
deliveri
rnai
therapeut
remain
key
hurdl
advanc
technolog
believ
develop
lipidoid
could
extend
scale
divers
avail
deliveri
solut
lipidoid
formul
sirna
antimir
demonstr
potent
specif
durabl
effect
gene
express
three
distinct
speci
includ
nonhuman
primat
therapeut
efficaci
observ
vivo
liver
lung
periton
macrophag
prior
studi
demonstr
success
silenc
lung
model
use
deliveri
reagent
howev
contrast
result
case
demonstr
substanti
improv
silenc
achiev
nake
sirna
note
gene
silenc
lung
continu
difficult
achiev
even
best
avail
lung
deliveri
formul
addit
knowledg
current
reagent
avail
demonstr
specif
endogen
gene
silenc
periton
macrophag
previou
report
base
deliveri
sirna
suggest
transittko
may
abil
data
demonstr
vivo
silenc
publish
believ
develop
librari
lipidlik
materi
repres
import
expans
divers
collect
intracellular
deliveri
materi
onestep
synthet
scheme
enabl
straightforward
parallel
gener
larg
librari
deliveri
materi
notabl
number
materi
identifi
vitro
vivo
util
common
structur
featur
materi
suggest
certain
design
criteria
creat
futur
intracellular
deliveri
agent
includ
amid
linkag
ii
two
alkyl
tail
iii
tail
length
rang
carbon
iv
secondari
amin
final
studi
warrant
investig
lipidoidbas
deliveri
rna
drug
extend
technolog
broadest
applic
rnai
therapi
drug
deliveri
lipidoid
synthes
addit
acrylamid
acryl
amin
amin
purchas
sigmaaldrich
tci
america
acryl
purchas
sigmaaldrich
dajac
monomerpolym
hampford
research
scientif
polym
tci
america
acrylamid
synthes
dropwis
addit
acryloyl
chlorid
appropri
see
supplementari
method
detail
ester
portion
lipidoid
librari
synthes
ratio
acrylateamin
solvent
unless
otherwis
specifi
amid
portion
lipidoid
librari
synthes
maxim
ratio
acylamideamin
amin
eg
acrylamideamin
amin
monom
librari
reaction
carri
teflonlin
glass
screwtop
vial
mg
amin
ad
correspond
amount
acryl
acrylamid
mixtur
stir
acryl
acrylamid
monom
respect
cool
lipid
mixtur
use
without
purif
unless
otherwis
specifi
sirna
oligoribonucleotid
synthes
alnylam
oligonucleotid
character
electrospray
mass
spectrometri
anionexchang
highperform
liquid
chromatographi
sequenc
sens
antisens
strand
sirna
follow
c
aaacaccauugucacacu
c
c
c
acacaacacugucacauu
c
c
c
aaacaccauugucacacu
c
c
c
acacaacacugucacauu
c
c
modifi
nucleotid
lower
case
modifi
nucleotid
bold
lower
case
phosphorothio
linkag
repres
asterisk
sirna
gener
anneal
equimolar
amount
complementari
sens
antisens
strand
protocol
adapt
ref
hela
cell
stabli
express
firefli
luciferas
renilla
luciferas
seed
cellswel
well
opaqu
white
plate
corningcostar
allow
attach
overnight
growth
medium
growth
medium
compos
phenol
redfre
dmem
fb
unitsml
penicillin
ml
streptomycin
invitrogen
cell
transfect
ng
fireflyspecif
siluc
complex
lipidoid
lipidoidsirna
ratio
wtwt
determin
optimum
transfect
effici
transfect
perform
quadrupl
work
dilut
lipid
prepar
concentr
necessari
yield
differ
lipidsirna
weight
ratio
sodium
acet
buffer
ph
ad
dilut
lipid
sirna
well
plate
mixtur
incub
min
allow
complex
format
lipidoidsirna
solut
ad
medium
polystyren
plate
growth
medium
remov
cell
use
aspir
wand
v
p
scientif
dmemlipidoidsirna
solut
immedi
ad
cell
allow
grow
co
analyz
luciferas
express
control
experi
perform
lipofectamin
describ
vendor
invitrogen
firefli
renilla
luciferas
express
analyz
use
dualglo
assay
kit
promega
luminesc
measur
use
luminomet
perkin
elmer
standard
curv
luciferas
gener
titrat
luciferas
enzym
promega
growth
medium
opaqu
white
plate
murin
bone
marrowderiv
macrophag
cultur
accord
standard
mice
express
gfp
control
rage
locu
promot
use
sourc
bone
marrow
cell
cultur
dish
presenc
ngml
macrophag
coloni
stimul
factor
mcsf
optim
sirnalipidoid
ratio
determin
lipidoid
ratio
either
wtwt
use
mixtur
sigfp
control
lipidoid
prepar
describ
lipofectamin
lipofectamin
rnaimax
invitrogen
complex
sirna
accord
manufactur
instruct
sirnalipidoid
mixtur
ad
macrophag
cultur
desir
concentr
h
medium
exchang
gfp
express
analyz
flow
cytometri
later
lipidoidbas
sirna
formul
compris
lipidoid
cholesterol
polyethylen
glycollipid
peglipid
sirna
formul
prepar
use
protocol
similar
describ
ref
stock
solut
mw
avanti
polar
lipid
mw
mpeg
dmg
mw
synthes
alnylam
see
supplementari
method
cholesterol
mw
sigmaaldrich
prepar
ethanol
mix
yield
molar
ratio
mix
lipid
ad
mm
sodium
acet
buffer
ph
yield
solut
contain
ethanol
result
spontan
format
empti
lipidoid
nanoparticl
result
nanoparticl
extrud
membran
two
pass
sirna
ethanol
mm
sodium
acet
ph
ad
nanoparticl
wtwt
sirnatot
lipid
incub
min
ethanol
remov
buffer
exchang
sirnacontain
lipidoid
nanoparticl
achiev
tangenti
flow
filtrat
pb
use
mwco
membran
final
formul
filter
steril
filter
particl
size
determin
use
malvern
zetas
nanoz
malvern
sirna
content
determin
uv
absorpt
nm
sirna
entrap
effici
determin
ribogreen
assay
result
particl
mean
particl
diamet
nm
peak
width
nm
sirna
entrap
effici
procedur
use
anim
studi
conduct
alnylam
approv
institut
anim
care
use
committe
iacuc
consist
local
state
feder
regul
applic
mice
charl
river
lab
spraguedawley
rat
charl
river
lab
receiv
either
salin
sirna
lipidoid
formul
via
tail
vein
inject
volum
mlg
variou
time
point
administr
anim
anesthet
isofluoran
inhal
blood
collect
serum
separ
tube
retroorbit
bleed
serum
level
factor
vii
protein
determin
sampl
use
chromogen
assay
coaset
factor
vii
diapharma
group
biophen
fvii
aniara
corpor
accord
manufactur
protocol
standard
curv
gener
use
serum
collect
salinetr
anim
experi
liver
mrna
level
assess
variou
time
point
administr
anim
kill
liver
harvest
snap
frozen
liquid
nitrogen
frozen
liver
tissu
ground
powder
tissu
lysat
prepar
liver
mrna
level
factor
vii
apob
determin
use
branch
dna
assay
quantigen
assay
panom
balbc
mice
harlan
spraguedawley
laboratori
anesthet
intraperiton
ip
administr
avertin
instil
intranas
lipidoidsirna
formul
total
volum
h
sirna
instil
mice
anesthet
infect
plaqueform
unit
pfu
respiratori
syncyti
viru
rsv
remov
lung
day
infect
anesthet
mice
exsanguin
sever
right
caudal
arteri
lung
tissu
collect
ice
pb
invitrogen
determin
viru
titer
rsv
titer
lung
measur
immunostain
plaqu
assay
lung
homogen
handheld
tissumis
homogen
fisher
scientif
lung
homogen
place
ice
min
allow
debri
settl
clarifi
lung
lysat
dilut
tenfold
serumfre
dmem
ad
confluent
vero
cell
cultur
dmem
plate
incub
h
follow
methylcellulos
overlay
postinfect
medium
remov
cell
fix
acetonemethanol
immunostain
plaqu
count
log
pfug
lung
versu
pb
sirna
mismatch
control
determin
mice
jackson
lab
inject
intraperiton
ml
brewer
thioglycol
medium
difco
inject
mgkg
sigfp
ip
four
mice
per
group
periton
lavag
collect
later
stain
fluorophoreconjug
antibodi
bd
bioscienc
flow
cytometri
sampl
run
lsrii
flowcytomet
bd
bioscienc
flowjo
softwar
treestar
use
identifi
high
low
macrophag
popul
quantifi
express
mice
charl
river
receiv
lipidoid
formul
antagomir
antimir
via
tail
vein
inject
mgkg
mgml
consecut
day
liver
taken
day
express
level
determin
liver
tissu
dissolv
proteinas
kcontain
cell
tissu
lysi
buffer
epicentr
subject
sonic
total
rna
extract
tesatur
phenol
roth
subsequ
precipit
ethanol
synthet
dna
probe
complementari
mous
well
mous
rna
label
use
polynucleotid
kinas
new
england
biolab
atp
ge
healthcar
probe
sequenc
cacgaatttgcgtgtcatccttgcgcaggggccatgttcttcttcttcttc
total
liver
rna
simultan
hybrid
solut
probe
probe
hybrid
condit
allow
detect
rna
matur
mirna
premirna
treatment
nucleas
sampl
load
denatur
acrylamid
gel
gel
expos
phosphoimag
screen
analyz
typhoon
instrument
ge
healthcar
rel
signal
intens
versu
calcul
sampl
assay
perform
describ
briefli
frozen
liver
tissu
lyse
ml
tissu
cell
lysi
buffer
epicentr
sonic
lysat
use
branch
dna
assay
depend
signal
strength
target
gene
probe
set
design
use
quantigen
probedesign
softwar
target
gene
express
assay
accord
quantigen
detect
assay
recommend
normal
correspond
glyceraldehyd
dehydrogenas
gapdh
housekeep
express
liver
tissu
lysat
procedur
use
cynomolgu
monkey
conduct
certifi
contract
research
organ
use
protocol
consist
local
state
feder
regul
applic
approv
institut
anim
care
use
committe
iacuc
cynomolgu
monkey
n
per
group
receiv
either
mlkg
pb
mgkg
formul
sicont
mlkg
mgkg
mlkg
formul
siapob
mgkg
mlkg
formul
siapob
bolu
iv
inject
via
brachial
vein
protein
measur
serum
collect
predos
administr
subsequ
experi
cynomolgu
monkey
n
per
group
receiv
either
mgkg
formul
sicont
mgkg
formul
siapob
bolu
iv
inject
via
saphen
vein
protein
measur
serum
collect
predos
h
administr
protein
determin
use
enzymelink
immunosorb
assay
previous
describ
clinic
chemistri
analyz
predos
h
administr
hematolog
coagul
paramet
analyz
predos
h
administr
anim
kill
h
liver
apob
mrna
level
determin
liver
sampl
use
branch
dna
assay
quantigen
assay
refer
web
version
pubm
central
supplementari
materi
vitro
screen
lipidoid
sirna
deliveri
hela
cell
express
firefli
renilla
luciferas
treat
firefli
luciferas
target
sirnalipidoid
complex
averag
percent
reduct
firefli
luciferas
activ
treatment
sirnalipidoid
complex
wtwt
ratio
quadrupl
shown
eas
analysi
data
group
follow
test
knockdown
b
optim
vitro
knockdown
lipidoid
hela
cell
lipidoid
optim
deliveri
use
four
lipidoidsirna
ratio
materi
test
quadrupl
data
present
optim
sirnalipidoid
wtwt
ratio
lipidoid
includ
sd
data
set
includ
lipidoid
signific
cytox
assess
signific
chang
renilla
luciferas
express
rel
untreat
cell
vivo
deliveri
sirna
liver
rodent
mice
n
receiv
two
daili
iv
inject
differ
lipidoid
formul
sirna
dose
mgkg
factor
vii
protein
level
quantifi
h
second
administr
b
simultan
silenc
two
gene
vivo
mice
mice
n
receiv
singl
iv
bolu
inject
formul
wtwt
mixtur
sifvii
siapob
mgkg
mgkg
sirna
comparison
control
anim
receiv
pb
lipidoidformul
sifvii
alon
lipidoidformul
siapob
alon
mgkg
fortyeight
hour
administr
anim
kill
liver
harvest
liver
mrna
level
factor
vii
apob
normal
gapdh
determin
branch
dna
vivo
deliveri
sirna
lung
periton
macrophag
deliveri
antimir
liver
inhibit
balbc
mous
lung
mice
n
intranas
administ
nake
sirna
lipidoidsirna
sirsv
mmsirsv
formul
dose
mgkg
lung
harvest
day
postinfect
assay
immunostain
plaqu
assay
b
inhibit
protein
thioglycol
elicit
mous
periton
macrophag
mice
n
inject
thioglycol
ip
treatment
mgkg
lipodoidformul
sigfp
administ
via
ip
inject
analyz
post
administr
express
macrophag
flow
cytometri
macrophag
cell
gate
median
fluoresc
intens
stain
plot
mfi
mean
fluoresc
intens
c
lipidoid
deliveri
vivo
nucleas
protect
assay
mirna
detect
liver
rna
sampl
three
repres
anim
per
treatment
group
shown
signal
serv
rna
input
control
anim
treat
show
mark
decreas
signal
lane
even
reduct
signal
observ
lipidoidformul
anim
lane
mismatch
control
antagomir
antimir
littl
effect
signal
lane
derepress
target
gene
inhibit
mice
mice
n
receiv
iv
inject
either
black
bar
gray
bar
daili
dose
mgkg
consecut
day
twentyfour
hour
last
inject
express
level
seven
report
target
gene
analyz
data
point
repres
group
mean
sd
data
point
mark
asterisk
statist
signific
rel
control
treat
group
p
p
p
ttest
singletail
vivo
deliveri
primat
extent
durat
serum
protein
reduct
cynomolgu
monkey
singl
bolu
iv
administr
lipidoidformul
sirna
group
except
salin
control
n
data
point
includ
n
data
point
salin
control
n
data
point
includ
n
data
point
beyond
data
point
repres
group
mean
sd
error
bar
shown
salin
group
n
bd
anim
n
treat
either
formul
control
sirna
mgkg
formul
apob
target
sirna
mgkg
formul
apob
target
sirna
mgkg
b
liver
apob
mrna
level
normal
gapdh
mrna
h
administr
c
serum
protein
reduct
h
administr
percentag
predos
level
ldlc
highdens
lipoprotein
hdl
cholesterol
level
h
administr
normal
predos
level
data
point
repres
group
mean
sd
data
point
mark
asterisk
statist
signific
rel
control
treat
group
p
p
p
ttest
singletail
tabl
clinic
chemistri
hematolog
paramet
lipidoidsirna
treat
rat
